VARANASI: A landmark Indian study, \"Unveiling Oral Cancer’s Molecular Blueprint: A Novel Classification to Guide Precision Therapy,\" published in the .
Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial. Analysis of event-free survival (EFS) of stromal tumor ...
A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease This retrospective analysis ...
In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...